Vitamin B12 is identified as the inhibitor of a key enzyme in hereditary Parkinson’s disease
Parkinson’s is the most common, chronic neurodegenerative movement disorder affecting 1% of the global population over seventy years of age. Right now, there is no cure for this disease and the available treatments focus on addressing its symptoms but not its progression. Although most cases of Parkinson’s are sporadic, the inheritable variants of the disease … Read more